Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · CBD

Is CBD legal in Saudi Arabia?

Confirmed against a primary sourceVerified October 8, 2026
Legal status
CBD of herbal origin is broadly prohibited in Saudi Arabia, with exceptions that the rule itself prints. CBD has its own rule in Saudi Arabia rather than an ordinary schedule entry. General Rule 9 of the schedules attached to the Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, in the version issued on 4 September 2026, addresses «مادة الكانابيديول (CBD)» and turns on origin, reaching CBD «المستخلصة أو المستحضرة من مصادر عشبية», extracted or prepared from herbal sources, subject to the exceptions the rule itself prints. The structure has three limbs. The first limb is that prohibition of herbal source CBD compounds. Wholly synthetic CBD can qualify for the stated exception where it carries no scheduled component. Approved herbal medicinal CBD products are brought within M/39 rather than left outside it. So the question a Saudi officer asks about a CBD product is where the molecule came from and what else is in the bottle, not whether the label says CBD. Cannabis itself remains at Schedule I Category A and tetrahydrocannabinol at Schedule II Category A.
Consequences if caught
Capital exposure here is conditional and the condition is the contents. The special 2026 CBD rule prohibits extensive conduct in its own terms but does not itself create a standalone Article 37 trigger, and Article 37 capital exposure requires either a scheduled narcotic or psychotropic constituent or a product that the CBD rule has brought within M/39. Where one of those is present, Article 37(I) is available and it states no quantity at all: the conduct named is smuggling, receipt from a smuggler, and import, export, manufacture, production, extraction or cultivation with intent to promote, with no weight threshold anywhere in it, and the death sentence is reducible by the court under Article 37(II) to a prison term of not less than fifteen years with the stated lashes and fine. No express life imprisonment wording was found anywhere in M/39. The practical trap is that most retail CBD oil is a herbal extract carrying residual THC, and THC is Schedule II Category A, so the constituent rather than the label decides which article applies.
If prescribed or medical
The Saudi traveller rule is a permit rule rather than a prescription rule. A controlled medicine may be brought in only under a clearance obtained from the SFDA before travel through its Controlled Drugs System, and that advance electronic clearance is required rather than optional. CBD's position under that rule depends on which limb of General Rule 9 the product falls into: an approved herbal medicinal CBD product is brought within M/39 and therefore inside the clearance regime, while a herbal source CBD compound that is not an approved product is on the prohibited side of the rule rather than the permitted side. A wholly synthetic CBD preparation with no scheduled component can qualify for the stated exception. A foreign prescription does not establish any of those limbs, and a certificate of analysis from the seller is not an SFDA determination.
Documentation
Do not carry a retail CBD product into the Kingdom on the strength of it being lawful where it was bought. If the product is an approved herbal medicinal CBD preparation, apply through the SFDA Controlled Drugs System before travelling and carry the clearance itself, with the medicine in its original dispensing packaging, the prescription and a medical report naming the patient, the active ingredient, the dose and the treatment period, translated into Arabic and dated less than six months before travel, and declare it at customs; advance electronic clearance has been required since 1 November 2025. The permit mechanics stated here are the SFDA traveller rules recorded on the current live cell and were not re-derived from the instrument in this pass. General Rule 9 was read in the 4 September 2026 schedules on 17 September 2026.
Primary sources
  • Saudi Arabia, General Rule 9 of the schedules attached to the Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, in the version issued on 4 September 2026, which governs cannabidiol by origin and prints its own exceptions, with M/39 Articles 1, 37 to 41 and 70 to 71 applying to scheduled constituents and to products brought within the Law
  • the schedules were read at https://sfda.gov.sa/sites/default/files/2026-09/%D8%A7%D9%84%D8%AC%D8%AF%D8%A7%D9%88%D9%84%20%D8%A7%D9%84%D9%85%D8%B1%D8%A7%D9%81%D9%82%D8%A9%20%D9%84%D9%86%D8%B8%D8%A7%D9%85%20%D9%85%D9%83%D8%A7%D9%81%D8%AD%D8%A9%20%D8%A7%D9%84%D9%85%D8%AE%D8%AF%D8%B1%D8%A7%D8%AA%20%D9%88%D8%A7%D9%84%D9%85%D8%A4%D8%AB%D8%B1%D8%A7%D8%AA%20%D8%A7%D9%84%D8%B9%D9%82%D9%84%D9%8A%D8%A9%202026.pdf, the Saudi Food and Drug Authority copy, and the penalty articles at https://www.moh.gov.sa/eServices/Licences/Documents/17.pdf, the Ministry of Health copy of M/39, with the statute text cross-checked against the readable transcription at https://github.com/Ahmed-Sleem/SaudiLegalCorpus
  • read as at 17 September 2026

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

CBD in related jurisdictions

Other substances confirmed in Saudi Arabia

Same substance, other countries